My Quote Request
6505-01-373-1449
20 Products
NDC50419-0188-01
GADOPENTETATE DEMIGLUMINE INJECTION,USP
NSN, MFG P/N
6505013731449
NSN
6505-01-373-1449
NDC50419-0188-01
GADOPENTETATE DEMIGLUMINE INJECTION,USP
NSN, MFG P/N
6505013731449
NSN
6505-01-373-1449
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 469.010 MILLIGRAMS GADOPENTETATE DIMEGLUMINE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GADOPENTETATE DEMIGLUMINE INJECTION USP 10ML VIAL 20S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
III THERAPEUTIC EQUIVALENT: MAGNEVIST BY BERLEX
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TOTAL PRIMARY CONTAINER QUANTITY: 20
Related Searches:
73402
DANTROLENE SODIUM FOR INJECTION
NSN, MFG P/N
6505013732802
NSN
6505-01-373-2802
73402
DANTROLENE SODIUM FOR INJECTION
NSN, MFG P/N
6505013732802
NSN
6505-01-373-2802
MFG
PROCTER & GAMBLE PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS DANTROLENE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 20 MILLIGRAMS ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CONTAINS 3000 MG MANNITO AND SUFFICIENT SODIUM HYDROXIDE TO YIELD A PH OF APPROX. 9.5; FOR RECONSTITUTION WATER FOR INJECTION WITHOUT BACTERIOSTATIC AGENT; FOR TREATMENT OF MALIGNANT HYPERTHERMIA
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00149-0734-02
DANTROLENE SODIUM FOR INJECTION
NSN, MFG P/N
6505013732802
NSN
6505-01-373-2802
NDC00149-0734-02
DANTROLENE SODIUM FOR INJECTION
NSN, MFG P/N
6505013732802
NSN
6505-01-373-2802
MFG
PROCTER & GAMBLE PHARMACEUTICALS INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS DANTROLENE SODIUM ACTIVE INGREDIENT
ADMINISTRATION: INTRAVENOUS
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 20 MILLIGRAMS ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: CONTAINS 3000 MG MANNITO AND SUFFICIENT SODIUM HYDROXIDE TO YIELD A PH OF APPROX. 9.5; FOR RECONSTITUTION WATER FOR INJECTION WITHOUT BACTERIOSTATIC AGENT; FOR TREATMENT OF MALIGNANT HYPERTHERMIA
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
BETAPACE
SOTALOL HYDROCHLORI
NSN, MFG P/N
6505013734314
NSN
6505-01-373-4314
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 80MG; 100 TABLETS PERBOTTLE; THERAPEUTICALLY EQUIVALENT BETAPACE BY BERLEX
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOTALOL HYDROCHLORIDE TABLETS 80MG 100S BT
Related Searches:
NDC50419-0105-10
SOTALOL HYDROCHLORI
NSN, MFG P/N
6505013734314
NSN
6505-01-373-4314
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 80MG; 100 TABLETS PERBOTTLE; THERAPEUTICALLY EQUIVALENT BETAPACE BY BERLEX
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOTALOL HYDROCHLORIDE TABLETS 80MG 100S BT
Related Searches:
BETAPACE
SOTALOL HYDROCHLORI
NSN, MFG P/N
6505013734315
NSN
6505-01-373-4315
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 240MG; UNIT DOSE; 100 TABLETS PER PACKAGE; THERAPEUTICALLY EQUIVALENT BETAPACE BERLEX
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOTALOL HYDROCHLORIDE TABLETS 240MG 100S PG
Related Searches:
NDC50419-0107-11
SOTALOL HYDROCHLORI
NSN, MFG P/N
6505013734315
NSN
6505-01-373-4315
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 240MG; UNIT DOSE; 100 TABLETS PER PACKAGE; THERAPEUTICALLY EQUIVALENT BETAPACE BERLEX
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOTALOL HYDROCHLORIDE TABLETS 240MG 100S PG
Related Searches:
BETAPACE
SOTALOL HYDROCHLORI
NSN, MFG P/N
6505013734316
NSN
6505-01-373-4316
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 240MG; 100 TABLETS PER BOTTLE; THERAPEUTICALLY EQUIVALENT BETAPACE BERLEX
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOTALOL HYDROCHLORIDE TABLETS 240MG 100S BT
Related Searches:
NDC50419-0107-10
SOTALOL HYDROCHLORI
NSN, MFG P/N
6505013734316
NSN
6505-01-373-4316
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 240MG; 100 TABLETS PER BOTTLE; THERAPEUTICALLY EQUIVALENT BETAPACE BERLEX
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOTALOL HYDROCHLORIDE TABLETS 240MG 100S BT
Related Searches:
BETAPACE
SOTALOL HYDROCHLORI
NSN, MFG P/N
6505013734317
NSN
6505-01-373-4317
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 160MG; UNIT DOSE; 100 TABLETS PER PACKAGE; THERAPEUTICALLY EQUIVALENT BETAPACE BERLEX
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOTALOL HYDROCHLORIDE TABLETS 160MG 100S PG
Related Searches:
NDC50419-0106-11
SOTALOL HYDROCHLORI
NSN, MFG P/N
6505013734317
NSN
6505-01-373-4317
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 160MG; UNIT DOSE; 100 TABLETS PER PACKAGE; THERAPEUTICALLY EQUIVALENT BETAPACE BERLEX
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOTALOL HYDROCHLORIDE TABLETS 160MG 100S PG
Related Searches:
BETAPACE
SOTALOL HYDROCHLORI
NSN, MFG P/N
6505013734318
NSN
6505-01-373-4318
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 80MG; UNIT DOSE; 100 TABLETS PER PACKAGE; THERAPEUTICALLY EQUIVALENT BETAPACE BERLEX
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOTALOL HYDROCHLORIDE TABLETS 80MG 100S PG
Related Searches:
NDC50419-0105-11
SOTALOL HYDROCHLORI
NSN, MFG P/N
6505013734318
NSN
6505-01-373-4318
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 80MG; UNIT DOSE; 100 TABLETS PER PACKAGE; THERAPEUTICALLY EQUIVALENT BETAPACE BERLEX
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOTALOL HYDROCHLORIDE TABLETS 80MG 100S PG
Related Searches:
BETAPACE
SOTALOL HYDROCHLORI
NSN, MFG P/N
6505013734319
NSN
6505-01-373-4319
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 160MG; 100 TABLETS PER BOTTLE; THERAPEUTICALLY EQUIVALENT BETAPACE BY BERLEX
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOTALOL HYDROCHLORIDE TABLETS 160MG 100S BT
Related Searches:
NDC50419-0106-10
SOTALOL HYDROCHLORI
NSN, MFG P/N
6505013734319
NSN
6505-01-373-4319
MFG
BAYER HEALTHCARE PHARMACEUTICALS INC. DBA BERLICHEM
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: 160MG; 100 TABLETS PER BOTTLE; THERAPEUTICALLY EQUIVALENT BETAPACE BY BERLEX
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SOTALOL HYDROCHLORIDE TABLETS 160MG 100S BT
Related Searches:
NDC00009-0029-46
ALPRAZOLAM TABLETS,USP
NSN, MFG P/N
6505013734322
NSN
6505-01-373-4322
NDC00009-0029-46
ALPRAZOLAM TABLETS,USP
NSN, MFG P/N
6505013734322
NSN
6505-01-373-4322
MFG
PHARMACIA & UPJOHN COMPANY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.250 MILLIGRAMS ALPRAZOLAM ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALPRAZOLAM TABLETS USP 0.25MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
Related Searches:
F93C175
GEMFIBROZIL TABLETS,USP
NSN, MFG P/N
6505013734323
NSN
6505-01-373-4323
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS GEMFIBROZIL ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GEMFIBROZIL TABLETS USP 600MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
NDC00182-1956-89
GEMFIBROZIL TABLETS,USP
NSN, MFG P/N
6505013734323
NSN
6505-01-373-4323
NDC00182-1956-89
GEMFIBROZIL TABLETS,USP
NSN, MFG P/N
6505013734323
NSN
6505-01-373-4323
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS GEMFIBROZIL ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GEMFIBROZIL TABLETS USP 600MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
NDC51079-0787-20
GEMFIBROZIL TABLETS,USP
NSN, MFG P/N
6505013734323
NSN
6505-01-373-4323
NDC51079-0787-20
GEMFIBROZIL TABLETS,USP
NSN, MFG P/N
6505013734323
NSN
6505-01-373-4323
MFG
UDL LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 600.000 MILLIGRAMS GEMFIBROZIL ACTIVE INGREDIENT
FEATURES PROVIDED: UNIT DOSE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: GEMFIBROZIL TABLETS USP 600MG 100S PG
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
Related Searches:
NDC00006-0735-82
SIMVASTAIN TABLETS,USP
NSN, MFG P/N
6505013737290
NSN
6505-01-373-7290
NDC00006-0735-82
SIMVASTAIN TABLETS,USP
NSN, MFG P/N
6505013737290
NSN
6505-01-373-7290
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS SIMVASTATIN ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SIMVASTAIN TABLETS USP 10MG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: ANTILIPEMIC AGENT